Exploratory Cross-sectional Study of Associations between Fatty Acid Metabolism Scintigraphy (123I-BMIPP test) in the Liver of Nonalcoholic Fatty Liver Disease (NAFLD) Patients and Serum Biomarkers and the Degree of Progression of NAFLD Pathology
Not Applicable
- Conditions
- nonalcoholic fatty liver disease
- Registration Number
- JPRN-UMIN000009841
- Lead Sponsor
- ational Center for Global Health and Medicine, Department of Gastroenterology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
a. Patients who have any other liver disease, such as chronic hepatitis C, chronic hepatitis B (HBs-Ag-positive patients), autoimmune hepatitis, primary biliary cirrhosis, primary sclerosing cholangitis, 1-antitrypsin deficiency, Wilson disease, or alcohol-related liver disease b. Patients who have a serious hepatic dysfunction, liver failure (encephalopathy, ascites, ruptured varices, or hyperbilirubinemia) c. Patients who have a serious renal dysfunction d. Patients who have a serious cardiopulmonary dysfunction e. Pregnant women, parturient women, breast-feeding women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method